SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-08-040961
Filing Date
2008-06-19
Accepted
2008-06-19 16:26:51
Documents
2
Period of Report
2008-04-30

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1577
2 EX-24 ex-24.htm EX-24 11034
  Complete submission text file 0001104659-08-040961.txt   14504
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERLEUKIN GENETICS, INC. 135 BEAVER STREET WALTHAM MA 02452
Business Address (781) 398-0700
Lurier Eliot M (Reporting) CIK: 0001438037 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 08908046